Real-Life check on promising myeloma drug combos
NCT ID NCT02970747
Summary
This study observed adults with relapsed multiple myeloma who were already prescribed specific drug combinations in real-world clinics. Its main goal was to see how well patients stuck with their treatment plans and how the treatments affected their quality of life and disease control outside of a controlled trial setting. It did not test new treatments but gathered information on how approved drug combinations are used in everyday practice.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA IN RELAPSE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centrum für Hämatologie und Onkologie Bethanien
Frankfurt, 60389, Germany
Conditions
Explore the condition pages connected to this study.